Opportunity Information: Apply for PAR 23 049

The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), is offering the NIDA Core "Center of Excellence" Grant Program using the P30 mechanism (PAR-23-049). This opportunity supports the creation or strengthening of a coordinated research center that unites investigators who already hold NIH or other federally or non-federally funded awards. The core idea is to make existing research efforts more effective and collaborative while deliberately extending and sharpening their relevance to drug abuse and addiction. Rather than funding isolated new projects, the program emphasizes shared infrastructure and coordination that helps multiple funded projects work together under a unifying theme, producing outcomes that are bigger than what each project could generate on its own.

A major expectation of this program is that the Center will push the field in meaningful, forward-leaning ways. NIDA signals clearly that incremental or routine extensions of current work should not be the main purpose of a P30 Center. Instead, applications are expected to propose new and creative directions made possible by integration across existing studies, disciplines, methods, and teams. In practice, that means the Center should be designed to "transform knowledge" in the scientific area it targets, for example by enabling cross-cutting approaches, shared data resources, harmonized measures, new analytic platforms, community or clinical linkages, or other core services that unlock novel science focused on addiction and related outcomes.

The structure of the application is expected to revolve around core activities that directly support and connect the participating investigators and their already-funded projects. Each core should clearly tie back to the Center's integrating theme, showing how it will accelerate discovery, improve rigor and efficiency, and create new opportunities that individual grants could not easily accomplish alone. Beyond supporting established investigators, the program places importance on developing the next generation of scientists: Centers are expected to provide research opportunities and experiences for new investigators. The program also stresses responsible sharing of findings, data, and resources, consistent with NIH expectations and with the overall goal of advancing addiction science through broader access to tools and knowledge generated by the Center.

The opportunity is listed as "Clinical Trial Optional," meaning the Center can include clinical trial-related activities if appropriate, but clinical trials are not required. The activity category is Education and Health, and the associated CFDA number is 93.279. The funding instrument is a discretionary grant. While the listing does not specify an award ceiling or the expected number of awards in the provided excerpt, the closing date shown is 2025-11-17, and the notice was created on 2022-12-28.

Eligibility is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations that are not federally recognized; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (other than institutions of higher education); for-profit organizations (other than small businesses); and small businesses. The announcement also highlights additional eligible applicant types such as Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), faith-based or community-based organizations, Hispanic-serving institutions, Historically Black Colleges and Universities (HBCUs), Tribally Controlled Colleges and Universities (TCCUs), eligible federal agencies, regional organizations, and U.S. territories or possessions.

Foreign eligibility is limited in a way that is typical for many NIH opportunities. Non-domestic (non-U.S.) entities and foreign institutions are not eligible to apply as the primary applicant organization. However, non-domestic components of U.S. organizations may participate, and foreign components (as defined in the NIH Grants Policy Statement) are allowed, which means international collaboration can be part of the work when justified and structured under an eligible U.S. applicant.

Overall, this P30 program is aimed at building a cohesive "Center of Excellence" that acts as a multiplier for ongoing funded research, using shared cores, common strategy, and coordinated expertise to generate innovative, field-shaping advances in drug abuse and addiction science, while also supporting new investigators and promoting meaningful data and resource sharing.

  • The National Institutes of Health in the education, health sector is offering a public funding opportunity titled "NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.279.
  • This funding opportunity was created on 2022-12-28.
  • Applicants must submit their applications by 2025-11-17. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
Apply for PAR 23 049

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Education, Health

Next opportunity: Mentored Career Development Program for Early Stage Investigators Using Nonhuman Primate Research Models (K01 Independent Clinical Trial Not Allowed)

Previous opportunity: NPS Cooperative Ecosystems Studies Units (CESU) Master Cooperative Agreements

Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for PAR 23 049

 

Applicants also applied for:

Applicants who have applied for this opportunity (PAR 23 049) also looked into and applied for these:

Funding Opportunity
Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed) Apply for PAR 23 088

Funding Number: PAR 23 088
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $150,000
NIDA Program Project Grant Applications (P01 Clinical Trial Optional) Apply for PAR 23 064

Funding Number: PAR 23 064
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA Research Center of Excellence Grant Program (P50 Clinical Trial Optional) Apply for PAR 23 076

Funding Number: PAR 23 076
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Required) Apply for PAR 23 107

Funding Number: PAR 23 107
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Career Enhancement Award to Advance Research on Firearm Injury and Mortality Prevention (K18 Independent Clinical Trial Not Allowed) Apply for PAR 23 108

Funding Number: PAR 23 108
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Accelerating the Pace of Drug Abuse Research Using Existing Data (R21 Clinical Trial Optional) Apply for RFA DA 24 037

Funding Number: RFA DA 24 037
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical Trial Not Allowed) Apply for RFA DA 24 027

Funding Number: RFA DA 24 027
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $300,000
Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R21 Clinical Trials Not Allowed) Apply for RFA DA 24 009

Funding Number: RFA DA 24 009
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $275,000
Leveraging Big Data Science to Elucidate the Mechanisms of HIV Activity and Interaction with Substance Use Disorder (R01 Clinical Trials Not Allowed) Apply for RFA DA 24 008

Funding Number: RFA DA 24 008
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $350,000
Advancing Integrated Models (AIM) of Care to Improve Pregnancy Outcomes among Women Who Experience Persistent Disparities (R01 Clinical Trial Optional) Apply for RFA NR 23 002

Funding Number: RFA NR 23 002
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Evaluating the Impact of Pandemic Era related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) Apply for RFA NR 23 003

Funding Number: RFA NR 23 003
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Clinical-Community Linkages to Address Social Needs and Social Conditions to Advance Health Equity among Populations Experiencing Health Disparities: The Bridge-to-Care Initiative (R01 Clinical Trial Required) Apply for RFA NR 23 004

Funding Number: RFA NR 23 004
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Ex Vivo Models for Studies at the Intersection of HIV and Poly-Substance Use (R01 Clinical Trial Not Allowed) Apply for RFA DA 24 001

Funding Number: RFA DA 24 001
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Genomic Community Resources (U24 Clinical Trial Not Allowed) Apply for PAR 23 124

Funding Number: PAR 23 124
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Addressing the Primary Care Needs of Cancer Survivors (U01 Clinical Trial Required) Apply for RFA CA 23 025

Funding Number: RFA CA 23 025
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $750,000
Avenir Award Program for Research on Substance Use Disorders and HIV (DP2 Clinical Trial Optional) Apply for PAR 23 125

Funding Number: PAR 23 125
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
Precompetitive Collaboration on Liquid Biopsy for Early Cancer Assessment: Data Management and Coordinating Unit (U24 Clinical Trial Not Allowed) Apply for RFA CA 23 031

Funding Number: RFA CA 23 031
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $450,000
Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional) Apply for PAR 23 122

Funding Number: PAR 23 122
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: Case Dependent
NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional) Apply for PAR 23 269

Funding Number: PAR 23 269
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $700,000
Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed) Apply for RFA CA 23 028

Funding Number: RFA CA 23 028
Agency: National Institutes of Health
Category: Education, Health
Funding Amount: $250,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

Inside Our Applicants Portal

  • Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
  • Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
  • Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Access Applicants Portal

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Learn More

 

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "PAR 23 049", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.

 

Ask a Question: